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Abstract
Radiation Therapy (XRT) is one of the most common cancer treatment methods.
In this paper, a new mathematical model is proposed for the population dynamics of
heterogeneous tumor cells following external beam radiation treatment. According to
the Target Theory, the tumor population is divided into m different subpopulations
based on the diverse effects of ionizing radiation on human cells. A hybrid model con-
sists of a system of differential equations with random variable coefficients representing
the transition rates between subpopulations is proposed. This model is utilized to sim-
ulate the dynamics of cell subpopulations within a tumor. The model also describes
the cell damage heterogeneity and the repair mechanism between two consecutive dose
fractions. As such, a new definition of tumor lifespan based on population size is intro-
duced. Finally, the stability of the system is studied by using the Gershgorin theorem.
It is proven that the probability of target inactivity post radiation plays the most
important role in the stability of the system.
1 Introduction
It has been experimentally verified that the ionization process initiated by radiating particles
leads to lesions in the cells [1]. The negative effect on DNA structure, makes lesions the most
harmful consequence of radiotherapy [2], [3]. Substantial progress has been made both in
the classification and evaluation of XRT treatment planning through probabilistic modeling.
The most well-known models are Tumor Control Probability (TCP) [4], [5], [6] and Normal
Tissue Complication Probability (NTCP) [7], [8].
There have been numerous advances in stochastic modeling of tumor response to radiation
treatment, including the linear quadratic model [4], [9], cell population dynamics models
[10], [11], [12], mixed-effects behavioral models [13] and cell cycle models [14]. However,
many of these models are constructed to evaluate certain important features of XRT, but
they do not incorporate biological tumor damage heterogeneity, which is the focus of our
study. We refer the reader to Michelson and Leith [15] for further information on different
1
ar
X
iv
:1
80
1.
07
11
3v
1 
 [q
-b
io.
QM
]  1
5 J
an
 20
18
types of heterogeneity.
The key concept in understanding XRT biology is the target theory [16]. A target is a
radio-sensitive site within a cell. Each cell contains a certain number of targets, which may
be deactivated after being hit by radiation particles. Moreover, between two consecutive
dose fractions, each target may become active again following immune system reaction [17].
Despite the development of several complex interpretations of the target theory, the essential
principle entails radiation-induced apoptosis of the organism on account of target(s) inac-
tivation within the organism. Although targets are considered functioning biological units
[18], the number of targets and their locations in an organism are not always clear. With re-
gard to cell sensitivity, the majority of models usually assume that cell sensitivity is constant
during radiation [19], [20], [21]. The same assumption is also made for cell populations, in
that the viability of a surviving cell is similar to an irradiated cell, i.e., all cells are assumed
to have the same survival probabilities. However, theses assumptions may not be completely
accurate, as there is strong evidence that damaged cells are unable to resist radiation [19],
[20].
The clinical significance of the intra-tumor heterogeneity of cell phenotypes and cell damage
is discussed in [22], and [23]. As such, providing a definition of a suitable treatment duration
is rather a clinical challenge, especially when considering therapeutic response variability.
In this regard, Keinj et al. developed a discrete-time Markov chain multinomial model for
tumor response [19], which employs the target theory. This model inspects the number of
surviving cells in the tumor but does not consider the tumor lifespan to be able to measure
the tumor’s response to treatment.
In this study, we model tumor population dynamics via a system of ordinary differential
equations. Thereafter, we evaluate the transition rates using a Markov chain. The model is
then applied to the special case of m = 3, which is related to the effect of radiation on cells
by dividing them into three subpopulations: cells with no effect (x0), cells with single-strand
break (x1) and cells with double-strand breaks (x2). In addition, we analyze the system’s
stability in this case as well as the system bifurcation with two parameters.
The paper is organized as follows: Section (2) introduces the general theory and prelim-
inary findings. In section (3), the tumor growth model is discussed terms of a system of
ordinary differential equations with Markov chain coefficients. The model calibration is pre-
sented in section (4). Thereafter, a new definition for tumor lifespan is proposed in section
(5). Three targets in each cell and the model parameters are employed to analytically inves-
tigate the obtained ODE system stability in section (6). Finally, section (7) concludes the
study.
2 Modeling assumptions and framework
We have considred the following assumptions in our modeling framework:
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1. Cells have the same phenotype but they act independently.
2. In the radiotherapy process, the magnitude of each dose fraction (u0) is constant during
treatment (i.e. u0 = 2 Gy). The time lag between two consecutive dose fractions is 24
hours.
3. Each cell consists of m targets, which may be deactivated with probability q after each
dose fraction. P(i, j) represents the treatment probability matrix in the transition from
i to j inactive targets, i.e., deactivating j targets when i targets has been disabled before
[19]. P(i, j) is written as:
P(i, j) =
{(m−i
j−i
)
qj−i(1− q)m−j
0
i ≤ j
j < i
(2.1)
4. Each target may be revived with probability r. As described previously [19], R(i, j)
represents the repair probability matrix in the transition from i to j, as given by:
R(i, j) =
{(i
j
)
ri−j(1− r)j
0
j ≤ i < m
i < j
(2.2)
where R(m,m) = 1 and R(m, j) = 0 for m 6= j.
5. xi indicates the cell subpopulation with i deactivated target(s), where i = 0, ..., (m−1).
For i 6= j, each cell can move from xi to xj with the constant time-independent
transition rate of α(i, j).
6. A cell will undergo radiation-induced apoptosis if all targets are deactivated. The cell
death rate in subpopulation xi is considered as constant, Di.
7. Cells can reproduce if all targets become active. For simplicity, we assume that just
before the repair mechanism acts, cells in subpopulation x0 can give birth to new cells
proportional to subpopulation x0 with a constant rate of β. As such, each cell in
subpopulation x0 can divide into exactly two daughter cells with probability µ or it
can remain unchanged with probability (1−µ) between two consecutive dose fractions.
3 Model derivation
As indicated in Fig. (1), tumor dynamics is generally described as the effect of radiotherapy
on the different tumor cell subpopulations. The conservation law for subpopulation xi’s,
i = 0, . . . ,m− 1 is written as follows. For i = 0:
dx0(t)
dt
= β x0(t)︸ ︷︷ ︸
Birth due to mitosis
+
m−1∑
j=1
α(j, 0)xj(t)︸ ︷︷ ︸
transition to x0
−
transition from x0︷ ︸︸ ︷[m−1∑
k=1
α(0, k)
]
x0(t)−
Death︷ ︸︸ ︷
D0 x0(t) (3.1)
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Figure 1: Schematic illustration of tumor cell population model.
and for i 6= 0:
dxi(t)
dt
=
m−1∑
j=0
j 6=i
α(j, i) xj(t)
︸ ︷︷ ︸
transition to xi
−
transition from xi︷ ︸︸ ︷[m−1∑
k=0
k 6=1
α(i, k)
]
xi(t)−
Death︷ ︸︸ ︷
Di xi(t) (3.2)
These equations produce the following system:
dx0(t)
dt
= β x0(t) +
m−1∑
j=1
α(j, 0) xj(t)−
[m−1∑
k=1
α(0, k) +D0
]
x0(t) (3.3)
dx1(t)
dt
=
m−1∑
j=0
j 6=1
α(j, 1) xj(t)−
[m−1∑
k=0
k 6=1
α(1, k) +D1
]
x1(t)
...
dxm−1(t)
dt
=
m−2∑
j=0
α(j,m− 1) xj(t)−
[m−2∑
k=0
α(m− 1, k) +Dm−1
]
xm−1(t)
4 Model Calibration
The probability that a cell will remain in x0 after radiation is P(0, 0). Therefore, the average
number of births in one day after applying the kth dose fraction and just before the (k+ 1)th
dose fraction is equal to:
n(k) = x0(k) µ P(0, 0)
= x0(k) µ(1− q)m (4.1)
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As seen in Eq. (4.1), the newborn cells’ population size is proportional to x0. Therefore, the
birth rate can be taken as:
β = µ(1− q)m (4.2)
Lemma 4.1. Suppose that a cell has i deactivated target(s) just before the application of a
dose fraction and Π = PR. After treatment and repair,
1. Π(i, j) represents the probability that a cell with i deactivated target(s) just before the
application of a dose fraction has j deactivated target(s) right before the application of
the next dose fraction.
2. An average number of xiΠ(i, j) cells move from xi into xj.
3. For fixed m and k ≥ 1, the map i→ Πk(i,m) is increasing.
Proof. 1. Suppose that Π = PR. Therefore:
Π(i, j) =
m∑
k=0
P(i, k)R(k, j) (4.3)
Eq. (2.2) shows that R(m, j) = 0 for j < m. Therefore:
Π(i, j) =
m−1∑
k=0
P(i, k)R(k, j) (4.4)
Now assume that a cell has i deactivated targets just before applying a dose frac-
tion. After radiation and right before the repair mechanism, this cell may remain
in subpopulation xi with probability P(i, i), or it may move to subpopulation xk,
k = i + 1, ..., (m − 1), with probability P(i, k). Following repair, this cell may move
from subpopulation xk to subpopulation xj with probability R(k, j). Therefore, the
probability of transitioning from subpopulation xi into subpopulation xj after treat-
ment and repair (one day) is Π(i, j).
2. The effect of treatment and repair on one cell is independent of the rest of the cells.
Therefore, the average number of cells moving from subpopulation xi into subpopula-
tion xj is equal to xiΠ(i, j).
3. See [20].
The following corollary is a direct consequence of lemma (4.1).
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Corollary 4.1. With the same assumptions described in Lemma (4.1):
1. The cells’ transition rate from subpopulation xi into subpopulation xj is equal to α(i, j) =
Π(i, j) (Day−1).
2. The death rate of subpopulation xi is Di = Π(i,m) (Day
−1).
Remark 4.1. According to lemma 4.1, we can separate the tumor cells into different sub-
populations according to their sensitivity to the radiation. Therefore, the death rate in a
subpopulation with more deactivated targets is higher than a subpopulation with fewer deac-
tivated targets, which can be interpreted as the treatment heterogeneity in the model.
Now, starting with subpopulation x0, cells give birth at a constant rate of µ(1−q)m (Day−1).
In addition, cells transit from subpopulation xi into subpopulation x0 at a rate of Π(i, 0) (Day
−1).
Conversely, cells move from subpopulation x0 into subpopulation xi at a rate of Π(0, i) (Day
−1)
or may die at a rate of Π(0,m) (Day−1), where Π is the transition matrix. Hence, for
i = 0, ..., (m− 1) we have:
m∑
l=0
Π(l, i) = 1 (4.5)
By substituting Eq. (4.5) in Eq. (3.1) we get:
dx0(t)
dt
= [Π(0, 0) + µ(1− q)m − 1] x0(t) +
m−1∑
l=1
Π(l, 0)xl(t) (4.6)
Same analysis shows that for i = 1, . . . , (m− 1):
dxi(t)
dt
=
m−1∑
l=0
l 6=i
Π(l, i) xl(t)− xi(t)
m∑
l=0
l 6=i
Π(i, l) (4.7)
By substituting Eq. (4.5) in Eq. (3.2) we get:
dxi(t)
dt
=
m−1∑
l=0
l 6=i
Π(l, i) xl(t)− xi [1− Π(i, i)] (4.8)
Finally, by substituting Eq. (4.6) and Eq. (4.8) in Eq. (3.3), the tumor growth model is
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described by:
dx0(t)
dt
= [Π(0, 0) + µ(1− q)m − 1] x0(t) +
m−1∑
l=1
Π(l, 0)xl(t) (4.9)
dx1(t)
dt
= [Π(1, 1)− 1] x1(t) +
m−1∑
l=0
l 6=1
Π(l, 1)xl(t).
...
dxm−1(t)
dt
= [Π(m− 1,m− 1)− 1] xm−1(t) +
m−2∑
l=0
Π(l,m− 1)xl(t).
with initial conditions x(0) = (n0, 0, ..., 0)
>.
5 Tumor lifespan
What dose magnitude is required to remove the tumor completely? A small number of
cells may still remain after resection, that are not visible and detectable by MRI. Therefore,
it is crucial to know how many dose fractions must be applied to eliminate the remaining
cancerous cells.
The tumor lifespan is defined as the minimum number of dose fractions required to remove
the entire tumor [24]. Therefore, based on tumor population dynamics, the tumor lifespan
is defined as:
L = min{btc : bN(t)c = 0} (5.1)
where
N(t) =
m−1∑
l=0
xl(t) + n(btc) (5.2)
6 Stability Analysis
Suppose that m is an arbitrary integer. System (4.9) can be written as:
x˙(t) = A(q, r) x(t) (6.1)
where matrix A is described as:
Atk =

Π(0, 0) + µ(1− q)m − 1 i, j = 0
Π(i, i)− 1 i = j and i 6= 0
Π(j, i) i 6= j
(6.2)
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where t = i+ 1 and k = j + 1. Therefore
A11 = Π(0, 0) + µ(1− q)m − 1
and for 2 ≤ t ≤ m
Att = Π(t− 1, t− 1)− 1 (6.3)
= Π(i, i)− 1
Let Am×m = (Atk) be a complex matrix. For t ∈ {1, ...,m} let Rt =
∑
k 6=t
|Atk| denote the
sum of the absolute values of the non-diagonal entries in the t-th row and D(Att, Rt) be the
closed disc centered at Att with radius Rt, which is known as Gershgorin disc. Eigenvalue of
A lies within at least one of the Gershgorin discs D(Att, Rt) (Gershgorin Theorem [25]).
Lemma 6.1. Suppose that B = A>. If Rt defines as
Rt =
∑
k 6=t
Btk (6.4)
then
1.
Rt > 0 (6.5)
2.
Btt +Rt =
 µ(1− q)m − qm i = 0−q(m−i) 1 ≤ i ≤ (m− 1) (6.6)
Proof. 1. According to (6.2), for 1 ≤ t ≤ m
Rt =
∑
k 6=t
Btk
=
∑
j 6=i
Π(i, j)
> 0 (6.7)
2. First consider that B = A> and t = 1. Therefore:
m∑
k=1
B1k = B11 +
m∑
k=2
B1k
= Π(0, 0) + µ(1− q)m − 1 +
m−1∑
j=1
Π(0, j)
= Π(0, 0) + µ(1− q)m − 1 + (1− Π(0, 0)− Π(0,m))
= µ(1− q)m − qm (6.8)
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Moreover, for 2 ≤ t ≤ m
m∑
k=1
Btk = Btt +
∑
k 6=t
Btk
= (Π(i, i)− 1) +
∑
j 6=i
Π(i, j)
= −Π(i,m)
= −qm−i (6.9)
The main result of this section is written as follows:
Theorem 6.1. For any m ≥ 2, 0 < µ ≤ 1 and 0 < r < 1, the system x˙ = A(q, r)x is stable
at equilibrium point 0, where q > 0.5.
Proof. It is enough to show that all eigenvalues of matrix A have negative real parts . To
provide this we will show that for any q > 0.5, 0 < r < 1 and m ≥ 2 any point of Gershgorin
circles D(Att, Rt) have negative real part, where 1 ≤ t ≤ m. For this purpose we apply
Gershgorin Theorem on matrix B = A>. Based on Lemma (6.1),
Btt +Rt =
 µ(1− q)m − qm i = 0−q(m−i) 1 ≤ i ≤ (m− 1) (6.10)
Note that the function qm is an increasing function for q > 0 and m is an integer. Therefore,
for 1− q < 0.5 < q we have:
µ(1− q)m < (1− q)m < qm (6.11)
where 0 ≤ µ ≤ 1.
Consequently, Btt ∈ R and Btt + Rt < 0 where q > 0.5 (Figure (2)). This shows that the
Gershgorin Circles belong to the left half of real line. In addition, according to Gershgorin
Theorem, each eigenvalue of matrix B belongs in one of Gershgorin discs. Therefore, each
eigenvalue of matrix B has negative real part. Hence, every eigenvalue of matrix A has
negative real part. This completes the proof.
Theorem 6.2. Suppose that m ≥ 2 is an integer, A ∈ Mm×m and the set S denotes the
value q such that the system (6.1) is stable corresponding to all 0 < r < 1 and 0 < µ ≤ 1.
Then:
inf
q
A = 0.5 (6.12)
Proof. According to Theorem (6.1), the system (4.9) is stable for q > 0.5. Now for any  > 0,
corresponding to q0 = 0.5 −  and for m = 2 there exists r0 = 1 −  such that the system
(4.9) is unstable. Hence:
inf
q
A = 0.5 (6.13)
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Figure 2: Gershgorin disc B(Att, Rt).
7 Conclusion
In this study, the population dynamics of tumor cells in the process of radiotherapy was
examined. A system of differential equations with random variable coefficients was intro-
duced to capture the heterogeneity of cell damage and the repair mechanism between two
consecutive dose fractions. Subsequently, a new definition for tumor lifespan was introduced
based on tumor population size. Based on the tumor lifespan, the effects of the probability
that a target will be inactive after a dose fraction (q) and the probability that a target will
reactivate after the repair mechanism (r) were investigated numerically. Our results are in
good agreement with previously presented results [20].
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